|PRODUCT NAME||CATALOG #||UNIT||PRICE||QTY||FAVORITES|
|COL1A1 Antibody (3G3)||sc-293182||100 µg/ml||$279.00||
See how others have used COL1A1 Antibody (L-19). Click on the entry to view the PubMed entry .
PMID: # 26658076
Chang, M.C. et al. 2015. Effects of Camphorquinone on Cytotoxicity, Cell Cycle Regulation and Prostaglandin E2 Production of Dental Pulp Cells: Role of ROS, ATM/Chk2, MEK/ERK and Hemeoxygenase-1. PloS one. 10: e0143663.
PMID: # 23812301
2014. Regeneration of Human Dermis by a Multi-Headed Peptide The Journal of investigative dermatology. 134: 58-67.
PMID: # 23348422
Kozono, S. et al. 2013. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells. Cancer Res.. 73: 2345-2356.
PMID: # 21597915
Ohto-Fujita, E. et al. 2011. Hydrolyzed eggshell membrane immobilized on phosphorylcholine polymer supplies extracellular matrix environment for human dermal fibroblasts. Cell Tissue Res.. 345: 177-190.
PMID: # 21738403
Zode, GS. et al. 2011. Transforming growth factor-β2 increases extracellular matrix proteins in optic nerve head cells via activation of the Smad signaling pathway. Molecular vision. 17: 1745-58.
PMID: # 19131643
Yasuoka, H. et al. 2009. The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration. American journal of respiratory cell and molecular biology. 41: 179-88.
PMID: # 19031438
Zode, GS. et al. 2009. Bone morphogenetic protein 4 inhibits TGF-beta2 stimulation of extracellular matrix proteins in optic nerve head cells: role of gremlin in ECM modulation. Glia. 57: 755-66.
PMID: # 19325816
Brüggemann, DA. et al. 2008. Muscle contraction and force: the importance of an ancillary network, nutrient supply and waste removal. Int J Mol Sci. 9: 1472-1488.
PMID: # 18467708
Hsu, E. et al. 2008. Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways. Am. J. Pathol.. 172: 1580-1590.
PMID: # 17283147
Yagüe, E. et al. 2007. Ability to acquire drug resistance arises early during the tumorigenesis process Cancer Res. 67(3): 1130-1137.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2018 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.